FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4315797426> ?p ?o ?g. }

• W4315797426 endingPage "14" @default.
• W4315797426 startingPage "8" @default.
• W4315797426 abstract "Purpose of the study . To evaluate the efficacy and safety of using a metabiotic preparation, which includes biologically active metabolites of the culture fluid of the probiotic bacterium Bacillus subtilis (B. subtilis) and fructooligosaccharides, for the correction of gastrointestinal symptoms in patients with post-COVID syndrome. Materials and methods of the study . The study included 40 outpatients with post-COVID syndrome aged 18 to 60 years (mean age 38.25–8.70 years), who, after undergoing COVID-19, were disturbed by gastrointestinal complaints and asthenia. Patients were randomized into 2 groups. Group 1 (n = 20) consisted of patients who received metabiotic capsules in the regimen of 1 capsule 2 times a day for 28 days; group 2 (n = 20) – patients who did not receive additional support. The observation period was 28 days. The severity of gastroenterological symptoms was assessed using the GSRS (Gastrointestinal Symptom Rating Scale) quality of life questionnaire, and asthenia was assessed using the Asthenic Condition Scale (ASS) by L.D. Malkova. Patients of group 1 (n = 10) additionally underwent a study of feces to quantify the composition of the microbiota of the colon by real-time polymerase chain reaction (PCR), test Kolonoflor-16. Research results . According to the results of assessing the quality of life in patients with post-COVID syndrome using the GSRS questionnaire, the main gastrointestinal complaints included: diarrhea, abdominal pain and dyspepsia; the severity in points was 14.1 points, 7.9 points, and 15.2 points, respectively, which corresponded to moderate manifestations of symptoms. Against the background of taking a metabiotic in patients of group 1, there was a statistically significant decrease in gastrointestinal complaints on the scale of the total measurement of symptoms (p < 0.0001), on the scales of abdominal pain syndrome (p < 0.0170), dyspeptic syndrome (p < 0.0001) and diarrheal syndrome (p < 0.0001). In patients of group 2 on the 28th day of the study, there was no significant change in symptoms. When assessing asthenia after taking metabotics, patients of the 1st group showed positive dynamics, the severity of asthenia before treatment was 51.5 ± 7.9 points, after treatment – 43.3 ± 5.9 points (p < 0.0500), in patients of group 2 there was no significant decrease in asthenic state indicators when assessed at the beginning and at the end of the observation period. On the 28th day, in patients of group 1 the representation of Lactobacillus spp. statistically significantly increased, normalization in the spectrum of Escherichia coli representation was noted, and the representation of UPM decreased. In the examined group, attention is drawn to the complete absence of Akkermansia muciniphila DNA in the feces of patients with post-COVID syndrome and the restoration of the representation of this bacterium after taking a metabiotic in 60 % of patients. Conclusions . In patients with post-COVID syndrome, the structure of gastrointestinal complaints is dominated by manifestations of abdominal pain, dyspeptic and diarrheal syndromes, and there are phenomena of colon dysbacteriosis, expressed in a decrease in the representation of obligate microflora and an increase in TMR. The use of metabolic tyranny in patients with post-COVID syndrome for 28 days in a regimen of 1 capsule 2 times a day is effective and safe." @default.
• W4315797426 created "2023-01-13" @default.
• W4315797426 creator A5004730888 @default.
• W4315797426 creator A5030003846 @default.
• W4315797426 creator A5038747240 @default.
• W4315797426 creator A5051431484 @default.
• W4315797426 creator A5061521315 @default.
• W4315797426 date "2023-01-12" @default.
• W4315797426 modified "2023-09-27" @default.
• W4315797426 title "Metabiotic based on metabolites of <i>Bacillus subtilis</i> for correction of gastrointestinal symptoms in patients with post-COVID syndrome" @default.
• W4315797426 cites W2904724764 @default.
• W4315797426 cites W2921943722 @default.
• W4315797426 cites W2954311903 @default.
• W4315797426 cites W3025878618 @default.
• W4315797426 cites W3033296569 @default.
• W4315797426 cites W3033469304 @default.
• W4315797426 cites W3044231852 @default.
• W4315797426 cites W3047833576 @default.
• W4315797426 cites W3081842677 @default.
• W4315797426 cites W3085847973 @default.
• W4315797426 cites W3118579072 @default.
• W4315797426 cites W3135229876 @default.
• W4315797426 cites W3144414218 @default.
• W4315797426 cites W3168198648 @default.
• W4315797426 cites W3187821926 @default.
• W4315797426 cites W3206237109 @default.
• W4315797426 cites W4220796823 @default.
• W4315797426 cites W4293089606 @default.
• W4315797426 cites W4307042774 @default.
• W4315797426 cites W4308968337 @default.
• W4315797426 doi "https://doi.org/10.33667/2078-5631-2022-35-8-14" @default.
• W4315797426 hasPublicationYear "2023" @default.
• W4315797426 type Work @default.
• W4315797426 citedByCount "0" @default.
• W4315797426 crossrefType "journal-article" @default.
• W4315797426 hasAuthorship W4315797426A5004730888 @default.
• W4315797426 hasAuthorship W4315797426A5030003846 @default.
• W4315797426 hasAuthorship W4315797426A5038747240 @default.
• W4315797426 hasAuthorship W4315797426A5051431484 @default.
• W4315797426 hasAuthorship W4315797426A5061521315 @default.
• W4315797426 hasBestOaLocation W43157974261 @default.
• W4315797426 hasConcept C126322002 @default.
• W4315797426 hasConcept C151730666 @default.
• W4315797426 hasConcept C159110408 @default.
• W4315797426 hasConcept C187212893 @default.
• W4315797426 hasConcept C2778271842 @default.
• W4315797426 hasConcept C2779134260 @default.
• W4315797426 hasConcept C2779802037 @default.
• W4315797426 hasConcept C2779951463 @default.
• W4315797426 hasConcept C2780255968 @default.
• W4315797426 hasConcept C2780955771 @default.
• W4315797426 hasConcept C2781413609 @default.
• W4315797426 hasConcept C2993801374 @default.
• W4315797426 hasConcept C3008058167 @default.
• W4315797426 hasConcept C523546767 @default.
• W4315797426 hasConcept C524204448 @default.
• W4315797426 hasConcept C54355233 @default.
• W4315797426 hasConcept C61716771 @default.
• W4315797426 hasConcept C71924100 @default.
• W4315797426 hasConcept C86803240 @default.
• W4315797426 hasConcept C90924648 @default.
• W4315797426 hasConceptScore W4315797426C126322002 @default.
• W4315797426 hasConceptScore W4315797426C151730666 @default.
• W4315797426 hasConceptScore W4315797426C159110408 @default.
• W4315797426 hasConceptScore W4315797426C187212893 @default.
• W4315797426 hasConceptScore W4315797426C2778271842 @default.
• W4315797426 hasConceptScore W4315797426C2779134260 @default.
• W4315797426 hasConceptScore W4315797426C2779802037 @default.
• W4315797426 hasConceptScore W4315797426C2779951463 @default.
• W4315797426 hasConceptScore W4315797426C2780255968 @default.
• W4315797426 hasConceptScore W4315797426C2780955771 @default.
• W4315797426 hasConceptScore W4315797426C2781413609 @default.
• W4315797426 hasConceptScore W4315797426C2993801374 @default.
• W4315797426 hasConceptScore W4315797426C3008058167 @default.
• W4315797426 hasConceptScore W4315797426C523546767 @default.
• W4315797426 hasConceptScore W4315797426C524204448 @default.
• W4315797426 hasConceptScore W4315797426C54355233 @default.
• W4315797426 hasConceptScore W4315797426C61716771 @default.
• W4315797426 hasConceptScore W4315797426C71924100 @default.
• W4315797426 hasConceptScore W4315797426C86803240 @default.
• W4315797426 hasConceptScore W4315797426C90924648 @default.
• W4315797426 hasIssue "35" @default.
• W4315797426 hasLocation W43157974261 @default.
• W4315797426 hasOpenAccess W4315797426 @default.
• W4315797426 hasPrimaryLocation W43157974261 @default.
• W4315797426 hasRelatedWork W1482883615 @default.
• W4315797426 hasRelatedWork W1766017500 @default.
• W4315797426 hasRelatedWork W2027370521 @default.
• W4315797426 hasRelatedWork W2378639844 @default.
• W4315797426 hasRelatedWork W2391751955 @default.
• W4315797426 hasRelatedWork W2549880305 @default.
• W4315797426 hasRelatedWork W2590959090 @default.
• W4315797426 hasRelatedWork W2807175397 @default.
• W4315797426 hasRelatedWork W3216395268 @default.
• W4315797426 hasRelatedWork W42192021 @default.
• W4315797426 isParatext "false" @default.
• W4315797426 isRetracted "false" @default.
• W4315797426 workType "article" @default.